Evoke plc EIHDF OTC · Consumer cyclical · Gibraltar
$0.63 +0.00% +$0.00
Summary
53 / 100 · Bulios Score
What speaks for it
- Revenue grew by 13% a year over the last 3 years.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 13% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of £552.6M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 29.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.